 |
|
Characteristics of Prostate Cancer in Families Potentially Linked to the Hereditary Prostate Cancer 1 (HPC1) Locus
Henrik Grönberg, MD, PhD;
Sarah D. Isaacs, MS;
Jeffrey R. Smith, MD;
John D. Carpten, PhD;
G. Steven Bova, MD;
Diha Freije, PhD;
Jianfeng Xu, MD, PhD;
Deborah A. Meyers, PhD;
Francis S. Collins, MD, PhD;
Jeffrey M. Trent, PhD;
Patrick C. Walsh, MD;
William B. Isaacs, PhD
JAMA. 1997;278(15):1251-1255.
Abstract
| |
Context.
—Approximately 9% of prostate cancer cases have been estimated to result from inheritance of mutated prostate cancer susceptibility genes. Few data exist as to whether there are clinical differences between prostate cancers that are inherited and those that occur in the general population.
Objective.
—To investigate phenotypic characteristics of families potentially linked to the hereditary prostate cancer 1 (HPC1) locus on chromosome 1q24-25.
Design.
—Retrospective case study in which clinical data were extracted from medical and pathological records.
Families.
—A total of 74 North American families with hereditary prostate cancer. Prostate cancer cases from the National Cancer Data Base were used as a reference population for comparison.
Main Outcome Measures.
—The families were divided into 2 groups: either potentially linked (33 families with 133 men with prostate cancer), and thus likely to be carrying an altered HPC1 gene, or potentially unlinked (41 families with 172 men with prostate cancer), on the basis of haplotype analysis in the region of HPC1. The age at diagnosis of prostate cancer, serum prostate-specific antigen levels, digital rectal examination status, stage, grade, primary treatment of prostate cancers, and occurrence of other cancers were compared between the groups.
Rresults.
—The mean age at diagnosis of prostate cancer for men in potentially linked families was significantly lower than for men in potentially unlinked families (63.7 vs 65.9 years, respectively, P=.01; mean age at diagnosis in the reference population was 71.6 years). Higher-grade cancers (grade 3) were more common in potentially linked families, and advanced-stage disease was found in 41% of the case patients in potentially linked families compared with 31% in both the potentially unlinked families and the reference groups (P=.03 for the latter comparison). In the other clinical parameters, we found no significant differences between the groups. A modest excess of breast cancer and colon cancer was found in potentially linked families in comparison with potentially unlinked families, but this difference was not statistically significant.
Conclusions.
—Families that provide evidence for segregation of an altered HPC1 gene are characterized by multiple cases of prostate cancer that, in most respects, are indistinguishable from nonhereditary cases. However, 3 characteristics were observed: younger age at diagnosis, higher-grade tumors, and more advanced-stage disease. Our study shows that a significant fraction of hereditary prostate cancers are diagnosed in advanced stages, emphasizing the clinical importance of early detection in men potentially carrying prostate cancer susceptibility genes. These findings support the current recommendations to screen men with a positive family history of prostate cancer beginning at age 40 years.
Author Affiliations
From the James Buchanan Brady Urological Institute (Drs Grönberg, Bova, Freije, Walsh, and Isaacs and Ms Isaacs) and the Department of Medicine (Drs Xu and Meyers), Johns Hopkins University, School of Medicine, Baltimore, Md; the National Human Genome Research Institute, National Institutes of Health, Bethesda, Md (Drs Smith, Carpten, Collins and Trent); and the Department of Oncology, Umeå University, Umeå, Sweden (Dr Grönberg). Drs Xu and Meyers are now affiliated with the Center for the Genetics of Asthma and Complex Diseases, University of Maryland School of Medicine, Baltimore.
Footnotes
Reprints: William B. Isaacs, PhD, James Buchanan Brady Urological Institute, Marburg 130B, The Johns Hopkins Hospital, 600 N Wolfe St, Baltimore, MD 21287-2101.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
RELATED LETTER
Prostate Cancer Potentially Linked to the HPC1 Gene
Marc E. Laniado and McClellan M. Walther
JAMA. 1998;279(7):507-508.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
CYP3A4 Polymorphisms--Potential Risk Factors for Breast and Prostate Cancer: A HuGE Review
Keshava et al.
Am J Epidemiol 2004;160:825-841.
ABSTRACT
| FULL TEXT
Evidence for Prostate Cancer-Associated Diagnostic Marker-1: Immunohistochemistry and in Situ Hybridization Studies
Ohkia et al.
Clin. Cancer Res. 2004;10:2452-2458.
ABSTRACT
| FULL TEXT
The complex genetic epidemiology of prostate cancer
Schaid
Hum Mol Genet 2004;13:R103-121.
ABSTRACT
| FULL TEXT
Ongoing Care of Patients After Primary Treatment for Their Cancer
Kattlove and Winn
CA Cancer J Clin 2003;53:172-196.
ABSTRACT
| FULL TEXT
RNASEL mutations in hereditary prostate cancer
Chen et al.
J. Med. Genet. 2003;40:e21-21.
FULL TEXT
Inherited Genotype and Prostate Cancer Outcomes
Rebbeck
Cancer Epidemiol. Biomarkers Prev. 2002;11:945-952.
ABSTRACT
| FULL TEXT
Perspective: Prostate Cancer Susceptibility Genes
Simard et al.
Endocrinology 2002;143:2029-2040.
FULL TEXT
Heterogeneity of genetic alterations in prostate cancer: evidence of the complex nature of the disease
Nwosu et al.
Hum Mol Genet 2001;10:2313-2318.
ABSTRACT
| FULL TEXT
Clinical Characteristics of Prostate Cancer in an Analysis of Linkage to Four Putative Susceptibility Loci
Goode et al.
Clin. Cancer Res. 2001;7:2739-2749.
ABSTRACT
| FULL TEXT
A Novel Human Cell Culture Model for the Study of Familial Prostate Cancer
Yasunaga et al.
Cancer Res. 2001;61:5969-5973.
ABSTRACT
| FULL TEXT
Assessing the effect of fatty acids on prostate carcinogenesis in humans: does self-reported dietary intake rank prostatic exposure correctly?
Freeman et al.
Am. J. Clin. Nutr. 2001;73:815-820.
ABSTRACT
| FULL TEXT
Equivalent Racial Outcome After Conformal Radiotherapy for Prostate Cancer: A Single Departmental Experience
Connell et al.
JCO 2001;19:54-61.
ABSTRACT
| FULL TEXT
A Genetic Epidemiological Study of Hereditary Prostate Cancer (HPC) in Finland: Frequent HPCX Linkage in Families with Late-onset Disease
Schleutker et al.
Clin. Cancer Res. 2000;6:4810-4815.
ABSTRACT
| FULL TEXT
Chapter 2: The Role of Steroid Hormones in Prostate Carcinogenesis
Bosland
J Natl Cancer Inst Monogr 2000;2000:39-66.
ABSTRACT
| FULL TEXT
The Polymorphic Exon 1 Androgen Receptor CAG Repeat in Men with a Potential Inherited Predisposition to Prostate Cancer
Lange et al.
Cancer Epidemiol. Biomarkers Prev. 2000;9:439-442.
ABSTRACT
| FULL TEXT
Confirmation of Prostate Cancer Susceptibility Genes Using High-Risk Families
Jarvik et al.
J Natl Cancer Inst Monogr 1999;1999:81-87.
ABSTRACT
| FULL TEXT
Linkage Analysis of 153 Prostate Cancer Families Over a 30-cM Region Containing the Putative Susceptibility Locus HPCX
Lange et al.
Clin. Cancer Res. 1999;5:4013-4020.
ABSTRACT
| FULL TEXT
Underreporting of Family History of Colon Cancer: Correlates and Implications
Glanz et al.
Cancer Epidemiol. Biomarkers Prev. 1999;8:635-639.
ABSTRACT
| FULL TEXT
Detection of Subclinical Cancers by Prostate-specific Antigen Screening in Asymptomatic Men from High-Risk Prostate Cancer Families
Matikainen et al.
Clin. Cancer Res. 1999;5:1275-1279.
ABSTRACT
| FULL TEXT
Molecular Genetics and Epidemiology of Prostate Carcinoma
Ruijter et al.
Endocr. Rev. 1999;20:22-45.
ABSTRACT
| FULL TEXT
Prostate Cancer Potentially Linked to the HPC1 Gene
Laniado and Walther
JAMA 1998;279:507-508.
FULL TEXT
Family History and Genetic Risk Factors: Forward to the Future
Pyeritz
JAMA 1997;278:1284-1285.
ABSTRACT
|
